Radiation boost may help immunotherapy work in tough colon cancers
NCT ID NCT07279077
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase II trial tests whether adding a special low-dose radiation therapy to standard chemotherapy and an immunotherapy drug can improve treatment for a type of colon cancer that usually doesn't respond well to immunotherapy alone. The study enrolls 38 adults with high-risk, locally advanced colon cancer. Participants receive four cycles of the combination therapy before surgery to remove the tumor. The main goal is to see if this approach leads to a complete disappearance of cancer cells in the removed tissue.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
low-dose radiotherapy, chemotherapy (CAPOX), and PD-1 inhibitor (immunotherapy)
What this could lead to
If successful, this combination could offer a more effective neoadjuvant treatment for a hard-to-treat colon cancer subtype, potentially increasing the chance of complete tumor disappearance before surgery.
What could go wrong
This is a small, early-phase trial (38 participants) with no control group. The approach is experimental, and the added radiotherapy may increase side effects without improving outcomes. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
The Sixth Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510655, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••